ArticleCancer diagnosis & prognosis

Post-treatment Neutrophil/Lymphocyte Ratio Is a Prognostic Factor in Head and Neck Cancers Treated With Nivolumab.

Yoh-Ichiro Iwasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.